{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:54:22Z","timestamp":1794963262062,"version":"4.9.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To systematically review the literature and synthesize evidence concerning the effects of vasopressin and its analogs compared with other vasopressors in distributive shock, focusing on renal outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Sources:<\/jats:title>\n            <jats:p>We performed a systematic review in MEDLINE, Embase, Cochrane Central, and Clinicaltrials.gov databases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study Selection:<\/jats:title>\n            <jats:p>Randomized clinical trials that compared vasopressin and its analogs with other vasopressors and reported renal outcomes in adult patients with distributive shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Extraction:<\/jats:title>\n            <jats:p>Paired reviewers independently screened citations, conducted data extraction and assessed risk of bias. Three prespecified subgroup analyses were conducted. Three main outcomes related to acute renal failure were analyzed: the need for renal replacement therapy, acute kidney injury incidence, and acute kidney injury-free days. <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> test was used to evaluate heterogeneity between studies. Substantial heterogeneity was defined as <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> greater than 50%. A random-effects model with Mantel-Haenszel weighting was used for all analyses. Heterogeneity was explored using subgroup analysis. The quality of evidence for intervention effects was summarized using Grading of Recommendations Assessment, Development, and Evaluation methodology. This study was registered in the PROSPERO database (CRD42017054324).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Synthesis:<\/jats:title>\n            <jats:p>Three-thousand twenty-six potentially relevant studies were identified, and 30 articles were reviewed in full. Seventeen studies met the inclusion criteria, including a total of 2,833 individuals. Of these, 11 studies (2,691 individuals) were suitable for quantitative meta-analysis. Overall, the evidence was of low to moderate quality. Patients who received vasopressin and its analogs had a reduced need for renal replacement therapy (odds ratio, 0.59 [0.37\u20130.92]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.02; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 49%) and a lower acute kidney injury incidence (odds ratio, 0.58 [0.37\u20130.92]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.02; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 63%). These results should be interpreted with caution, due to excessive heterogeneity. Acute kidney injury-free data was not pooled, since the small number of studies and extreme heterogeneity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In patients with distributive shock, vasopressin and its analogs use is associated with a reduced need for renal replacement therapy and lower acute kidney injury incidence. These results are supported by high risk of bias evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000003471","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:02:19Z","timestamp":1539129739000},"page":"e44-e51","source":"Crossref","is-referenced-by-count":34,"title":["Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials"],"prefix":"10.1097","volume":"47","author":[{"given":"Wagner L.","family":"Nedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana H.","family":"Rech","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Porto Alegre, Brazil."},{"name":"Post-Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Post-Graduate Program in Epidemiology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil."},{"name":"Faculdade Meridional (IMED-RS), Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Augusto S.","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael B.","family":"Moraes","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Porto Alegre, Brazil."},{"name":"Intensive Care Unit, Grupo Hospitalar Concei\u00e7\u00e3o (GHC), Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016.","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock.","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress.","volume":"24","author":"D\u00fcnser","year":"2009","journal-title":"J Intensive Care Med"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"e0129305","DOI":"10.1371\/journal.pone.0129305","article-title":"Vasopressors for the treatment of septic shock: Systematic review and meta-analysis.","volume":"10","author":"Avni","year":"2015","journal-title":"PLoS One"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"e0142605","DOI":"10.1371\/journal.pone.0142605","article-title":"Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials.","volume":"10","author":"Belletti","year":"2015","journal-title":"PLoS One"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1097\/CCM.0b013e318169167f","article-title":"Vasoactive drugs and acute kidney injury.","volume":"36","author":"Bellomo","year":"2008","journal-title":"Crit Care Med"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00134-017-4755-7","article-title":"Acute kidney injury in sepsis.","volume":"43","author":"Bellomo","year":"2017","journal-title":"Intensive Care Med"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00134-015-3849-3","article-title":"What\u2019s new in vasopressin?","volume":"41","author":"O\u2019Callaghan","year":"2015","journal-title":"Intensive Care Med"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2215\/CJN.03681106","article-title":"Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes.","volume":"2","author":"Bagshaw","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2215\/CJN.04360514","article-title":"A prospective international multicenter study of AKI in the intensive care unit.","volume":"10","author":"Bouchard","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s001340101014","article-title":"The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series.","volume":"27","author":"Holmes","year":"2001","journal-title":"Intensive Care Med"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock.","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock.","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial.","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): A randomized, controlled pilot study.","volume":"13","author":"Morelli","year":"2009","journal-title":"Crit Care"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0168-8278(09)60176-8","article-title":"Clinical efficacy and safety of terlipressin administration in cirrhotic patients with septic shock.","volume":"50","author":"Acevedo","year":"2009","journal-title":"J Hepatol"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","article-title":"Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study.","volume":"33","author":"Alban\u00e8se","year":"2005","journal-title":"Crit Care Med"},{"key":"R19-20230728","first-page":"15","article-title":"The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: Microcirculation, is it the black box?","volume":"54","author":"Barzegar","year":"2016","journal-title":"Acta Med Iran"},{"key":"R20-20230728","first-page":"254A","article-title":"A prospective open label randomized noninferiority trial to compare the efficacy and safety of monotherapy with noradrenaline and terlipressin in patients of cirrhosis with septic shock admitted to the intensive care unit (nct01836224).","volume":"60","author":"Choudhury","year":"2014","journal-title":"Hepatology"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study.","volume":"107","author":"D\u00fcnser","year":"2003","journal-title":"Circulation"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial.","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1186\/cc7349","article-title":"Vasopressin versus norepinephrine infusion in patients with vasoplegic shock after cardiac surgery.","volume":"13","author":"Hajjar","year":"2009","journal-title":"Crit Care"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","article-title":"Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial.","volume":"32","author":"Lauzier","year":"2006","journal-title":"Intensive Care Med"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","article-title":"Low-dose vasopressin in the treatment of vasodilatory septic shock.","volume":"47","author":"Malay","year":"1999","journal-title":"J Trauma"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aen017","article-title":"Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: The DOBUPRESS study.","volume":"100","author":"Morelli","year":"2008","journal-title":"Br J Anaesth"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.jvca.2014.07.007","article-title":"Vasopressin does not raise cardiac enzymes following cardiac surgery: A randomized double-blind clinical trial.","volume":"29","author":"Okamoto","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","article-title":"Beneficial effects of short-term vasopressin infusion during severe septic shock.","volume":"96","author":"Patel","year":"2002","journal-title":"Anesthesiology"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jss.2015.07.016","article-title":"Effects of terlipressin on patients with sepsis via improving tissue blood flow.","volume":"200","author":"Xiao","year":"2016","journal-title":"J Surg Res"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock.","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study.","volume":"107","author":"D\u00fcnser","year":"2003","journal-title":"Circulation"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock.","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aen017","article-title":"Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: The DOBUPRESS study.","volume":"100","author":"Morelli","year":"2008","journal-title":"Br J Anaesth"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bja\/aev284","article-title":"The effect of inotropes and vasopressors on mortality: A meta-analysis of randomized clinical trials.","volume":"115","author":"Belletti","year":"2015","journal-title":"Br J Anaesth"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/cc12640","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: A systematic review and meta-analysis of nine randomized controlled trials.","volume":"17","author":"Pereira","year":"2013","journal-title":"Crit Care"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: A systematic review and meta-analysis.","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00134-017-4820-2","article-title":"How to improve the care of patients with acute kidney injury.","volume":"43","author":"Bellomo","year":"2017","journal-title":"Intensive Care Med"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/cc6840","article-title":"Competing risks models and time-dependent covariates.","volume":"12","author":"Barnett","year":"2008","journal-title":"Crit Care"},{"key":"R39-20230728","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.athoracsur.2006.11.044","article-title":"Actual and actuarial probabilities of competing risks: Apples and lemons.","volume":"83","author":"Grunkemeier","year":"2007","journal-title":"Ann Thorac Surg"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201901000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T09:51:50Z","timestamp":1690537910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201901000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000003471","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}